The purpose of this study is to assess the occurrence of osteonecrosis of the jaw (ONJ) for 3 years in cancer patients with bone metastasis receiving zoledronic acid treatment.
Basic Eligibility Criteria:
If you would like information about enrolling into a clinical trial at El Camino Hospital, please contact:
Clinical Research Coordinator
Fogarty Clinical Research